Market Updates
U.S. Movers: Apple, Amgen, Expedia
Scott Peters
03 May, 2024
New York City
Apple Inc. soared 6% to $183.44 after the maker of popular iPhone devices reported better-than-expected sales and earnings in its fiscal second quarter.
Revenue in the fiscal second quarter ending in March declined to $90.7 billion from $94.8 billion, net income fell to $23.6 billion from $24.2 billion, and diluted earnings per share increased to $1.53 from $1.52 a year ago.
Net sales in the Americas declined to $37.3 billion from $37.8 billion; in the European Union, they rose to $24.1 billion from $23.9 billion; in Greater China, they decreased to $16.3 billion from $17.8 billion; in Japan, they fell to $6.2 billion from $7.2 billion; and in the rest of Asia Pacific, they eased to $6.7 billion from $8.2 billion a year ago, respectively.
The company's board of directors increased its quarterly cash dividend by 4% to 25 cents per share, payable on May 16 to shareholders on record on May 13.
The company also announced a whopping $110 billion stock repurchase plan.
Expedia decreased 12% to $119.52 after the online travel booking platform reported better-than-expected revenue in the first quarter.
However, stock fell sharply after the company estimated full-year revenue growth in the range of mid- to high single-digits, disappointing some investors.
Amgen soared 14% to $316.11 after the biotech company reported better-than-expected quarterly results and said it would no longer pursue the development of an experimental weight-loss pill.
However, the company plans to take injectable obesity drugs into a phase 3 trial, following the encouraging results in phase two.
Annual Returns
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|
Earnings
| Company | Ticker | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|